Rizvi MA - Search Results

1

Drug-induced thrombocytopenia: a systematic review of published case reports.

George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T. George JN, et al. Among authors: rizvi ma. Ann Intern Med. 1998 Dec 1;129(11):886-90. doi: 10.7326/0003-4819-129-11_part_1-199812010-00009. Ann Intern Med. 1998. PMID: 9867731 Review.

2

Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review.

Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN. Vesely SK, et al. Among authors: rizvi ma. Ann Intern Med. 2004 Jan 20;140(2):112-20. doi: 10.7326/0003-4819-140-3-200402030-00012. Ann Intern Med. 2004. PMID: 14734334 Review.

3

Drug-induced thrombocytopenia.

Rizvi MA, Shah SR, Raskob GE, George JN. Rizvi MA, et al. Curr Opin Hematol. 1999 Sep;6(5):349-53. doi: 10.1097/00062752-199909000-00013. Curr Opin Hematol. 1999. PMID: 10468152 Review.

4

Drug-induced thrombocytopenia: an updated systematic review.

Rizvi MA, Kojouri K, George JN. Rizvi MA, et al. Ann Intern Med. 2001 Feb 20;134(4):346. doi: 10.7326/0003-4819-134-4-200102200-00030. Ann Intern Med. 2001. PMID: 11182857 No abstract available.

5

Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes.

Roy V, Rizvi MA, Vesely SK, George JN. Roy V, et al. Among authors: rizvi ma. Bone Marrow Transplant. 2001 Mar;27(6):641-6. doi: 10.1038/sj.bmt.1702849. Bone Marrow Transplant. 2001. PMID: 11319595

6

Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome.

Rizvi MA, Vesely SK, George JN, Chandler L, Duvall D, Smith JW, Gilcher RO. Rizvi MA, et al. Transfusion. 2000 Aug;40(8):896-901. doi: 10.1046/j.1537-2995.2000.40080896.x. Transfusion. 2000. PMID: 10960513

7

T-cell non-Hodgkin lymphoma.

Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST. Rizvi MA, et al. Blood. 2006 Feb 15;107(4):1255-64. doi: 10.1182/blood-2005-03-1306. Epub 2005 Oct 6. Blood. 2006. PMID: 16210342 Free article. Review.

8

Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines.

Rizvi MA, Ghias K, Davies KM, Ma C, Weinberg F, Munshi HG, Krett NL, Rosen ST. Rizvi MA, et al. Among authors: ma c. Mol Cancer Ther. 2006 Jul;5(7):1783-9. doi: 10.1158/1535-7163.MCT-05-0465. Mol Cancer Ther. 2006. PMID: 16891464

9

The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway.

Querfeld C, Rizvi MA, Kuzel TM, Guitart J, Rademaker A, Sabharwal SS, Krett NL, Rosen ST. Querfeld C, et al. Among authors: rizvi ma. J Invest Dermatol. 2006 Jul;126(7):1641-7. doi: 10.1038/sj.jid.5700322. Epub 2006 Apr 27. J Invest Dermatol. 2006. PMID: 16645590 Free article.

10

Exploring cyclopropylamine containing cyanopyrimidines as LSD1 inhibitors: Design, synthesis, ADMET, MD analysis and anticancer activity profiling.

Ahmad Sheikh K, Parveen D, Mumtaz Alam M, Azam F, Ahmed Khan M, Akhter M, Tasneem S, Meenu, Parvez S, Imtiyaz K, Rizvi MA, Shaquiquzzaman M. Ahmad Sheikh K, et al. Among authors: rizvi ma. Bioorg Chem. 2024 Apr 16;147:107336. doi: 10.1016/j.bioorg.2024.107336. Online ahead of print. Bioorg Chem. 2024. PMID: 38636431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page